News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GILL SIMBA
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 1,996 shares
@ $3.94, valued at
$7.9k
Granted 60,000 restricted stock units
@ $0
Exercised 15,000 restricted stock units
@ $0 |
|
| 08/09/2023 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 342 shares
@ $9.51, valued at
$3.3k
Exercised 1,171 restricted stock units
@ $0 |
|
| 06/12/2023 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $0.97, valued at
$970k
|
|
| 05/10/2023 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Sold 3,537 shares
@ $0.1255, valued at
$443.9 |
|
| 05/10/2023 |
4/A
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 23,437 restricted stock units
@ $0 |
|
| 05/09/2023 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Exercised 23,437 restricted stock units
@ $0 |
|
| 02/09/2023 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 1,125,000 options to buy
@ $0.97, valued at
$1.1M
Granted 375,000 restricted stock units
@ $0 |
|
| 09/14/2022 |
4
| GILL SIMBA (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Gifted 47,939 shares
@ $0
Exercised 82,000 options to buy
@ $0.73, valued at
$59.9k
|
|
| 06/22/2022 |
4
| GILL SIMBA (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 16,000 options to buy
@ $13.81, valued at
$221k
|
|
| 01/21/2022 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 300,000 options to buy
@ $5.05, valued at
$1.5M
|
|
| 07/14/2021 |
4
| GILL SIMBA (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 12,530 options to buy
@ $9.4, valued at
$117.8k
|
|
| 01/29/2021 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 275,000 options to buy
@ $16.65, valued at
$4.6M
|
|
| 10/22/2020 |
3
| GILL SIMBA (Director) has filed a Form 3 on Foghorn Therapeutics Inc. |
| 01/30/2020 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 250,000 options to buy
@ $7.06, valued at
$1.8M
|
|
| 01/16/2019 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 220,000 options to buy
@ $13.71, valued at
$3M
|
|
| 05/10/2018 |
4
| GILL SIMBA (President & CEO) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 145,869 options
@ $16, valued at
$2.3M
|
|
| 05/08/2018 |
3
| GILL SIMBA (President & CEO) has filed a Form 3 on Evelo Biosciences, Inc. |
|
|